Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Accenture
Harvard Business School
US Army
Cipla
Cantor Fitzgerald
Medtronic
AstraZeneca

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GADOPENTETATE DIMEGLUMINE

« Back to Dashboard

Clinical Trials for Gadopentetate Dimeglumine

Trial ID Title Status Sponsor Phase Summary
NCT00004936 MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients Completed National Cancer Institute (NCI) N/A RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients.
NCT00004936 MRI and CT Scans to Evaluate Invasive Cervical Cancer Before Treating Patients Completed American College of Radiology Imaging Network N/A RATIONALE: Imaging procedures such as MRI or CT scans may improve the ability to detect cervical cancer and determine the extent of disease. PURPOSE: Diagnostic trial to determine the effectiveness of MRI and CT scans in evaluating invasive cervical cancer before treatment of patients.
NCT00033397 Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery Active, not recruiting National Cancer Institute (NCI) N/A RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer.
NCT00033397 Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery Active, not recruiting Alliance for Clinical Trials in Oncology N/A RATIONALE: Comparing results of diagnostic procedures performed before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: Diagnostic trial to study magnetic resonance imaging (MRI) and biomarkers in women who are receiving chemotherapy before surgery for locally advanced breast cancer.
NCT00310544 Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction Completed Bayer Phase 2 The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Gadopentetate Dimeglumine

Condition Name

Condition Name for Gadopentetate Dimeglumine
Intervention Trials
Adult Anaplastic Oligodendroglioma 2
Adult Giant Cell Glioblastoma 2
Adult Anaplastic Ependymoma 2
Adult Anaplastic Astrocytoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Gadopentetate Dimeglumine
Intervention Trials
Astrocytoma 2
Brain Neoplasms 2
Oligodendroglioma 2
Gliosarcoma 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Gadopentetate Dimeglumine

Trials by Country

Trials by Country for Gadopentetate Dimeglumine
Location Trials
United States 20
Argentina 1
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Gadopentetate Dimeglumine
Location Trials
California 4
Pennsylvania 2
North Carolina 2
New York 2
New Jersey 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Gadopentetate Dimeglumine

Clinical Trial Phase

Clinical Trial Phase for Gadopentetate Dimeglumine
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 1
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Gadopentetate Dimeglumine
Clinical Trial Phase Trials
Completed 7
Terminated 2
Withdrawn 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Gadopentetate Dimeglumine

Sponsor Name

Sponsor Name for Gadopentetate Dimeglumine
Sponsor Trials
National Cancer Institute (NCI) 4
Bracco Diagnostics, Inc 2
Bayer 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Gadopentetate Dimeglumine
Sponsor Trials
Other 10
Industry 5
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Cerilliant
Argus Health
AstraZeneca
Merck
Johnson and Johnson
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.